The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Folinic Acid (as Calcium Folinate) 15mg Tablets

Pfizer Healthcare IrelandPA0822/198/001

Main Information

Trade NameFolinic Acid (as Calcium Folinate) 15mg Tablets
Active SubstancesFolinic acid
Dosage FormTablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/198/001

Group Information

ATC CodeV03AF Detoxifying agents for antineoplastic treatment
V03AF03 calcium folinate


License statusAuthorised
Licence Issued28/07/1986
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back